Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform

Sally Anliker

Sally Anliker is the director of regulatory affairs CMC at Eli Lilly and Company

Articles by Sally Anliker